Drug development for hepatocellular carcinoma

Lancet Oncol. 2023 Dec;24(12):1292-1294. doi: 10.1016/S1470-2045(23)00523-5.
No abstract available

MeSH terms

  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / pathology
  • Drug Development
  • Humans
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / pathology